Kitakami, Japan

Kazutaka Ueda


Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazutaka Ueda: Innovator in Antimicrobial Agents

Introduction

Kazutaka Ueda is a notable inventor based in Kitakami, Japan. He has made significant contributions to the field of antimicrobial agents, particularly through his work on lincomycin derivatives. With a total of three patents to his name, Ueda's innovations are aimed at addressing the challenges posed by resistant bacterial strains.

Latest Patents

Ueda's latest patents focus on lincomycin derivatives and antimicrobial agents that utilize these compounds as active ingredients. One of his inventions provides novel compounds that are effective against resistant strains of bacteria, which have become a growing concern in the treatment of infectious diseases. These compounds are designed to be pharmacologically acceptable salts or solvates, showcasing a range of structural variations that enhance their efficacy. Another patent highlights lincomycin derivatives that demonstrate potent activity against resistant pneumococci, further emphasizing their potential in preventing and treating bacterial infections.

Career Highlights

Kazutaka Ueda is associated with Meiji Seika Kaisha, Ltd., where he has been instrumental in advancing research and development in antimicrobial therapies. His work has not only contributed to the scientific community but also has practical implications for public health.

Collaborations

Ueda has collaborated with notable colleagues such as Yoshinari Wakiyama and Kou Kumura. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective research efforts.

Conclusion

Kazutaka Ueda's innovative work in the field of antimicrobial agents positions him as a key figure in combating bacterial resistance. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…